Regulation of telomerase reverse transcriptase gene activity by upstream stimulatory factor

Oncogene

Volumn 22, Issue 39, 2003, Pages 8042-8047

  Goueli, Basem S ^a   Janknecht, Ralf ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

E box; Human telomerase reverse transcriptase (hTERT); Myc; Transcription; Upstream regulatory factor (USF)

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; PROTEIN P300; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG; UPSTREAM STIMULATORY FACTOR 1; UPSTREAM STIMULATORY FACTOR 2;

ARTICLE; CELL IMMORTALIZATION; CELL STIMULATION; CONTROLLED STUDY; E BOX ELEMENT; ENZYME INHIBITION; GENE ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; ONCOGENE MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; SOMATIC CELL; TRANSCRIPTION REGULATION;

EID: 0345549479     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206847     Document Type: Article

References (32)

1. Aisner DL, Wright WE and Shay JW. (2002). Curr. Opin. Genet. Dev., 12, 80-85.
2. Blackburn EH. (2001). Cell, 106, 661-673.
3. Bosc DG, Goueli BS and Janknecht R. (2001). Oncogene, 20, 6215-6224.
4. Bredemeier-Ernst I, Nordheim A and Janknecht R. (1997). FEBS Lett., 408, 47-51.
5. Breen GA and Jordan EM. (1999). Biochim. Biophys. Acta, 1428, 169-176.
6. Dhaene K, Wauters J, Weyn B, Timmermans JP and van Marck E. (2000). J. Pathol., 190, 80-85.
7. Dillner NB and Sanders MM. (2002). J. Biol. Chem., 277, 33890-33894.
8. Drissi R, Zindy F, Roussel MF and Cleveland JL. (2001). J. Biol. Chem., 276, 29994-30001.
9. Ducrest AL, Amacker M, Mathieu YD, Cuthbert AP, Trott DA, Newbold RF, Nabholz M and Lingner J. (2001). Cancer Res., 61, 7594-7602.
10. Ducrest AL, Szutorisz H, Lingner J and Nabholz M. (2002). Oncogene, 21, 541-552.
11. Galibert MD, Carreira S and Goding CR. (2001). EMBO J., 20, 5022-5031.
12. Goodman RH and Smolik S. (2000). Genes Dev., 14, 1553-1577.
13. Gregor PD, Sawadogo M and Roeder RG. (1990). Genes Dev., 4, 1730-1740.
14. Heckert LL. (2001). Mol. Endocrinol., 15, 704-715.
15. Hiyama E and Hiyama K. (2002). Oncogene, 21, 643-649.
16. Horikawa I, Cable PL, Mazur SJ, Appella E, Afshari CA and Barrett JC. (2002). Mol. Biol. Cell, 13, 2585-2597.
17. Horiuchi K, Fujimoto D, Fukushima M and Kanai K. (1981). Cancer Res., 41, 1488-1491.
18. Janknecht R. (2002). Histol. Histopathol., 17, 657-668.
19. Kumari D and Usdin K. (2001). J. Biol. Chem., 276, 4357-4364.
20. Kuo MH and Allis CD. (1999). Methods, 19, 425-433.
21. Kyo S, Takakura M, Taira T, Kanaya T, Itoh H, Yutsudo M, Ariga H and Inoue M. (2000). Nucleic Acids Res., 28, 669-677.
22. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, Strickler JE, McLaughlin MM, Siemens IR, Fisher SM, Livi GP, White JR, Adams JL and Young PR. (1994). Nature, 372, 739-746.
23. Liu SL, Rand A, Kelm Jr RJ and Getz MJ. (2000). Oncogene, 19, 3352-3362.
24. Muhlethaler-Mottet A, Di Berardino W, Otten LA and Mach B. (1998). Immunity, 8, 157-166.
25. Pearson KL, Hunter T and Janknecht R. (1999). Biochim. Biophys. Acta, 1489, 354-364.
26. Poole JC, Andrews LG and Tollefsbol TO. (2001). Gene, 269, 1-12.
27. Sirito M, Lin Q, Maity T and Sawadogo M. (1994). Nucleic Acids Res., 22, 427-433.
28. Sirito M, Walker S, Lin Q, Kozlowski MT, Klein WH and Sawadogo M. (1992). Gene Expr., 2, 231-240.
29. Viollet B, Lefrancois-Martinez AM, Henrion A, Kahn A, Raymondjean M and Martinez A. (1996). J. Biol. Chem., 271, 1405-1415.
30. Won J, Yim J and Kim TK. (2002a). FASEB J., 16, 1943-1945.
31. Won J, Yim J and Kim TK. (2002b). J. Biol. Chem., 277, 38230-38238.
32. Yago M, Ohki R, Hatakeyama S, Fujita T and Ishikawa F. (2002). FEBS Lett., 520, 40-46.